Bionano Genomics, Inc.

NasdaqCM:BNGO Stock Report

Market Cap: US$11.5m

Bionano Genomics Management

Management criteria checks 3/4

Bionano Genomics' CEO is Robert Holmlin, appointed in Jan 2011, has a tenure of 15.17 years. total yearly compensation is $989.68K, comprised of 60.6% salary and 39.4% bonuses, including company stock and options. directly owns 0.01% of the company’s shares, worth $1.11K. The average tenure of the management team and the board of directors is 5.6 years and 7.3 years respectively.

Key information

Robert Holmlin

Chief executive officer

US$989.7k

Total compensation

CEO salary percentage60.63%
CEO tenure15.2yrs
CEO ownership0.01%
Management average tenure5.6yrs
Board average tenure7.3yrs

Recent management updates

Recent updates

Market Cool On Bionano Genomics, Inc.'s (NASDAQ:BNGO) Revenues

Jan 30
Market Cool On Bionano Genomics, Inc.'s (NASDAQ:BNGO) Revenues

A Piece Of The Puzzle Missing From Bionano Genomics, Inc.'s (NASDAQ:BNGO) 28% Share Price Climb

Sep 14
A Piece Of The Puzzle Missing From Bionano Genomics, Inc.'s (NASDAQ:BNGO) 28% Share Price Climb

Investors Continue Waiting On Sidelines For Bionano Genomics, Inc. (NASDAQ:BNGO)

Jul 30
Investors Continue Waiting On Sidelines For Bionano Genomics, Inc. (NASDAQ:BNGO)
User avatar

VIA Software And Optical Genome Mapping Will Improve Laboratory Efficiency

Enhancements in customer utilization and lab efficiency are projected to boost consumable sales and revenue growth.

Revenues Working Against Bionano Genomics, Inc.'s (NASDAQ:BNGO) Share Price Following 26% Dive

Apr 05
Revenues Working Against Bionano Genomics, Inc.'s (NASDAQ:BNGO) Share Price Following 26% Dive

Slammed 62% Bionano Genomics, Inc. (NASDAQ:BNGO) Screens Well Here But There Might Be A Catch

Feb 11
Slammed 62% Bionano Genomics, Inc. (NASDAQ:BNGO) Screens Well Here But There Might Be A Catch

Bionano Genomics, Inc. (NASDAQ:BNGO) Might Not Be As Mispriced As It Looks

Dec 17
Bionano Genomics, Inc. (NASDAQ:BNGO) Might Not Be As Mispriced As It Looks

Many Still Looking Away From Bionano Genomics, Inc. (NASDAQ:BNGO)

Aug 29
Many Still Looking Away From Bionano Genomics, Inc. (NASDAQ:BNGO)

CEO Compensation Analysis

How has Robert Holmlin's remuneration changed compared to Bionano Genomics's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2025n/an/a

-US$39m

Jun 30 2025n/an/a

-US$74m

Mar 31 2025n/an/a

-US$84m

Dec 31 2024US$990kUS$600k

-US$112m

Sep 30 2024n/an/a

-US$136m

Jun 30 2024n/an/a

-US$204m

Mar 31 2024n/an/a

-US$227m

Dec 31 2023US$1mUS$599k

-US$232m

Sep 30 2023n/an/a

-US$227m

Jun 30 2023n/an/a

-US$147m

Mar 31 2023n/an/a

-US$140m

Dec 31 2022US$3mUS$544k

-US$133m

Sep 30 2022n/an/a

-US$117m

Jun 30 2022n/an/a

-US$106m

Mar 31 2022n/an/a

-US$92m

Dec 31 2021US$8mUS$484k

-US$72m

Sep 30 2021n/an/a

-US$61m

Jun 30 2021n/an/a

-US$51m

Mar 31 2021n/an/a

-US$41m

Dec 31 2020US$708kUS$376k

-US$41m

Sep 30 2020n/an/a

-US$37m

Jun 30 2020n/an/a

-US$33m

Mar 31 2020n/an/a

-US$32m

Dec 31 2019US$899kUS$404k

-US$30m

Compensation vs Market: Robert's total compensation ($USD989.68K) is above average for companies of similar size in the US market ($USD575.90K).

Compensation vs Earnings: Robert's compensation has been consistent with company performance over the past year.

CEO

Robert Holmlin (57 yo)

15.2yrs
Tenure
US$989,677
Compensation

Dr. Robert Erik Holmlin, Ph D., M.B.A. has been the Chief Executive Officer and President of BioNano Genomics, Inc. (alternatively BioNanomatrix, Inc.) since January 12, 2011 and served as its Secretary &...

Leadership Team

NamePositionTenureCompensationOwnership
Robert Holmlin
President15.2yrsUS$989.68k0.0097%
$ 1.1k
Mark Oldakowski
Chief Operating Officer8.3yrsUS$663.37k0.0063%
$ 730.2
Alka Chaubey
Chief Medical Officer5.6yrsUS$661.91k0.0063%
$ 727.9
Mark Adamchak
VP of Accounting & Controller7.8yrsno data0.0026%
$ 294.4
Jonathan Dixon
General Counsel & Secretary4yrsno data0.0026%
$ 296.7
Donna Polizio
Global Head of Market Access3.3yrsno datano data
Cory Kreeck
Global Head of People Operations4.2yrsno datano data
5.6yrs
Average Tenure
51yo
Average Age

Experienced Management: BNGO's management team is seasoned and experienced (5.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Robert Holmlin
President15.2yrsUS$989.68k0.0097%
$ 1.1k
Christopher Twomey
Independent Director7.7yrsUS$76.86k0.0010%
$ 120.7
David Barker
Independent Director15.8yrsUS$91.09k0.00095%
$ 109.2
Albert Luderer
Independent Chairman14.4yrsUS$87.62k0%
$ 0
Hannah Mamuszka
Independent Director5.8yrsUS$64.36k0.0011%
$ 123.0
Kristiina Vuori
Independent Director6.8yrsUS$74.36k0%
$ 0
Yvonne Linney
Independent Director5.8yrsUS$61.86k0%
$ 0
Aleksandar Rajkovic
Independent Director4.1yrsUS$61.86k0%
$ 0
7.3yrs
Average Tenure
62yo
Average Age

Experienced Board: BNGO's board of directors are considered experienced (7.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/11 23:02
End of Day Share Price 2026/03/11 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bionano Genomics, Inc. is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yi ChenH.C. Wainwright & Co.
Jason McCarthyMaxim Group
Kevin DeGeeterOppenheimer & Co. Inc.